Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesBayer AG NA

Bayer AG NA

PortfolioPortfolio WatchlistWatchlist
Company price
None GBX 0.00(0%)
Last update at 2026-10-28T03:28:42.395398Z
Market Cap
51695.16M

Momentum Score

…

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
20.37
Low
49.78
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
45.87
Dividend Yield
0.19%
Revenue TTM
45575.00M
Revenue Per Share
46.39
Gross Profit TTM
27048.00M
Debt / Equity
1.09
ROE
-12.37%
Net Debt
-
ROCE
11.40%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax - - -17250.00M 2853.00M 1886.00M
Net income - - -10495.00M 4091.00M 1695.00M
Selling general administrative - - 15980.00M 16156.00M 14881.00M
Gross profit - - 22262.00M 25932.00M 21361.00M
Ebit 9121.00M 7475.00M 6972.00M 6980.00M 4257.00M
Operating income - - -16169.00M 4162.00M 3454.00M
Other operating expenses 528.00M 296.00M 69.00M 59.00M 1477.00M
Interest expense - 0.00M 0.00M 0.00M 0.00M
Tax provision - - -1689.00M 443.00M 496.00M
Interest income - - 976.00M 1052.00M 1239.00M
Extraordinary items - - 5074.00M 1700.00M 321.00M
Income tax expense 504.00M 1024.00M -1689.00M 443.00M 496.00M
Total revenue - - 41400.00M 43545.00M 36742.00M
Cost of revenue - - 19138.00M 17613.00M 15381.00M
Discontinued operations - - 5074.00M 1700.00M 321.00M
Net income applicable to common shares 4150.00M 1000.00M -10495.00M 4091.00M 1695.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets - - 116763.00M 126174.00M 126732.00M
Intangible assets - - 25416.00M 34709.00M 36696.00M
Other current assets 521.00M 545.00M 674.00M 1534.00M 794.00M
Total liab - - 86240.00M 78921.00M 80755.00M
Total stockholder equity - - 30523.00M 47253.00M 45977.00M
Deferred long term liab 3797.00M 4312.00M 4383.00M 5517.00M 5253.00M
Other current liab 16105.00M 17097.00M 21306.00M 13329.00M 12128.00M
Common stock 2515.00M 2515.00M 2515.00M 2515.00M 2387.00M
Retained earnings 17233.00M 13345.00M 13057.00M 26151.00M 25734.00M
Other liab 17076.00M 21189.00M 16160.00M 18614.00M 19747.00M
Good will - - 36395.00M 39126.00M 38442.00M
Other assets 10481.00M 10299.00M 9920.00M 10742.00M 10113.00M
Cash - - 4191.00M 3185.00M 4052.00M
Total current liabilities 35084.00M 29403.00M 36768.00M 23215.00M 23125.00M
Short long term debt total - - 33196.00M 36907.00M 37708.00M
Other stockholder equity 19025.00M 17160.00M 14951.00M 18587.00M 17856.00M
Property plant equipment 13674.00M 12688.00M 11723.00M 12479.00M 12943.00M
Total current assets 37760.00M 32578.00M 35675.00M 32439.00M 31065.00M
Net tangible assets -21294.00M -29044.00M -26965.00M -21277.00M -23954.00M
Short term investments - - 7940.00M 2219.00M 950.00M
Net receivables 13450.00M 12980.00M 12157.00M 14851.00M 14137.00M
Long term debt - - 33196.00M 35955.00M 37359.00M
Inventory 13636.00M 11314.00M 10961.00M 10650.00M 11132.00M
Accounts payable 7545.00M 6792.00M 5678.00M 6426.00M 6038.00M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - -2978.00M 4302.00M -4027.00M
Change to liabilities - - 612.00M 854.00M -347.00M
Total cashflows from investing activities - - -2381.00M 855.00M -4073.00M
Net borrowings - - -974.00M -2452.00M 4467.00M
Total cash from financing activities - - -4220.00M -5645.00M 423.00M
Change to operating activities - - -1407.00M 436.00M 9220.00M
Net income -2552.00M -2941.00M 4150.00M 1000.00M -10495.00M
Change in cash - - 607.00M 373.00M 1006.00M
Total cash from operating activities - - 7093.00M 5089.00M 4903.00M
Depreciation - - 3949.00M 3740.00M 3444.00M
Other cashflows from investing activities - - 218.00M 137.00M 134.00M
Dividends paid - - 1985.00M 1993.00M 2751.00M
Change to inventory - - -2170.00M -173.00M -900.00M
Change to account receivables - - 269.00M -61.00M 695.00M
Other cashflows from financing activities - - -1251.00M -1200.00M -1293.00M
Change to netincome - - 1690.00M -707.00M 3286.00M
Capital expenditures 0.00M 0.00M 2949.00M 2611.00M 2418.00M
Change in working capital - - - - 6000.00M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0R15
SoftBank Group Corp.		 248.00
5.84%		 4494.00 - - - -
0R1E
Nintendo Co. Ltd.		 -115.00
1.34%		 8476.00 - - - -
0LC3
Synchrony Financial		 2.34
3.20%		 75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A		 0.15
0.12%		 122.47 0.25 - 1.18 -

Profile*

Bayer AG NA

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Kaiser-Wilhelm-Allee 1, Leverkusen, Germany, 51368

49 214 30 1

https://www.bayer.com

87280

Name Title Year Born
Mr. Werner Baumann Chairman of Management Board, CEO & Chief Sustainability Officer 1962
Mr. Wolfgang U. Nickl CFO & Member of Management Board 1969
Mr. Heiko W. J. Schipper Member of Management Board & Pres of the Consumer Health Division 1969
Mr. Stefan Oelrich Head of the Pharmaceuticals Division & Member of the Board of Management 1968
Ms. Sarena S. Lin Chief Transformation & Talent Officer, Labor Director and Member of Management Board 1971
Mr. Rodrigo Santos Member of Management Board & Pres of the Crop Science Division 1973
Mr. Bernd-Peter Bier Head of Accounting and Head of Taxes 1967
Mr. Oliver Maier Head of Investor Relations NA
Dr. Gabriel Harnier Head of Law, Patents & Compliance 1971
Mr. Michael Preuss Head of Communications, Gov. Relations and Corp. Brand NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…